Suspected EPS/Acute Dystonia
Patient on dopamine-blocking agent with movement disorder
All Pathways
PsychiatryEmergency
Acute Dystonia & Extrapyramidal Symptoms (EPS) Management
Acute Dystonia & Extrapyramidal Symptoms (EPS) Management: Suspected EPS/Acute Dystonia → Identify Type of EPS → ⚠️ ACUTE DYSTONIA → Immediate Treatment...
Pathway Overview
13 steps
Algorithm Steps
13 total
01Start 02Decision Identify Type of EPS
Different syndromes require different management
03Warning ⚠️ ACUTE DYSTONIA
Sustained muscle contractions - EMERGENCY
- Onset: Within 48-72 hours of starting/increasing dose
- 90% occur within first 5 days
- Torticollis (neck twisting)
- Oculogyric crisis (eyes rolled back)
- Trismus (jaw clenching)
- Laryngeal dystonia (stridor - AIRWAY EMERGENCY)
- Opisthotonos (arched back)
04Action Immediate Treatment
Anticholinergic reversal
- BENZTROPINE 1-2mg IM or IV
- - Onset: 5-15 minutes
- - Can repeat in 30 min if needed
- OR DIPHENHYDRAMINE 25-50mg IM or IV
- - Alternative if benztropine unavailable
- Relief usually within minutes
- ⚠️ If laryngeal dystonia: Secure airway first!
05Action Prophylaxis After Dystonia
Prevent recurrence
- Continue oral anticholinergic 48-72 hours
- Benztropine 1-2mg BID or
- Trihexyphenidyl 2mg BID
- Consider prophylaxis when starting high-potency AP
- Risk factors: young, male, high-potency FGA
06Decision Need to Continue Antipsychotic?
Evaluate ongoing need
07Action Consider Switching Antipsychotic
Lower EPS risk options
- Quetiapine (low EPS risk)
- Clozapine (lowest EPS risk)
- Aripiprazole (partial agonist)
- Avoid high-potency FGAs if EPS history
08Action Ongoing Monitoring
Use standardized scales
- AIMS (Abnormal Involuntary Movement Scale) q3-6mo
- Barnes Akathisia Rating Scale
- Simpson-Angus Scale for parkinsonism
- Monitor for tardive dyskinesia (chronic EPS)
09Outcome EPS Managed
Ongoing prevention and monitoring
- Educate patient about EPS recognition
- Carry anticholinergic if high-risk
- Regular movement disorder screening
- Early intervention prevents complications
- Path rejoins step 08Shared downstream outcome
10Action Akathisia
Inner restlessness, inability to sit still
- Onset: Days to weeks after starting
- Subjective inner restlessness
- Pacing, rocking, inability to sit
- Can be misdiagnosed as anxiety/agitation
- Associated with suicidality if untreated
11Action Akathisia Treatment
Beta-blockers or benzodiazepines
- First-line: PROPRANOLOL 10-20mg TID
- - Most evidence; well-tolerated
- Alternative: LORAZEPAM 0.5-1mg BID-TID
- Consider reducing antipsychotic dose
- Anticholinergics less effective for akathisia
- Mirtazapine 15mg may help
- Path rejoins step 06Shared downstream outcome
12Action Drug-Induced Parkinsonism
Bradykinesia, rigidity, tremor
- Onset: Weeks to months
- Tremor (pill-rolling, resting)
- Cogwheel rigidity
- Bradykinesia
- Masked facies
- Shuffling gait
13Action Parkinsonism Treatment
Anticholinergics or dose reduction
- Reduce antipsychotic dose if possible
- Switch to lower D2-binding SGA
- BENZTROPINE 0.5-2mg BID
- - Or trihexyphenidyl 2-5mg BID-TID
- AMANTADINE 100mg BID alternative
- Monitor for anticholinergic side effects
- Path rejoins step 06Shared downstream outcome
Guideline Source
Extrapyramidal Side Effects Management - StatPearls/Standard Protocols
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Acute dystonia requires immediate treatment - can be life-threatening (laryngeal)
- Must differentiate from other causes of abnormal movements
- Tardive dyskinesia requires different management
- Some EPS may not respond fully to anticholinergics
Applicable Regions
USEUGlobal
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
PHQ-9 (Patient Health Questionnaire-9)
Depression screening and severity assessment
Open page
Compare
AttendMe.ai vs ChatGPT
See how this pathway workflow compares against ChatGPT.
Open page
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Start free
Related Resources
Frequently Asked Questions
What is the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management?
The Acute Dystonia & Extrapyramidal Symptoms (EPS) Management is a emergency clinical algorithm for Psychiatry. It provides a structured decision tree to guide clinical decision-making, based on Extrapyramidal Side Effects Management - StatPearls/Standard Protocols.
What guideline is the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management based on?
This algorithm is based on Extrapyramidal Side Effects Management - StatPearls/Standard Protocols.
What are the limitations of the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management?
Known limitations include: Acute dystonia requires immediate treatment - can be life-threatening (laryngeal); Must differentiate from other causes of abnormal movements; Tardive dyskinesia requires different management; Some EPS may not respond fully to anticholinergics. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free